Taking Products to Market


Over the years, Rubicon has developed and scaled up several drug products. In 2016, Rubicon successfully scaled up its 100th product. Several of these products have been commercialized from third party manufacturing sites across the world.

Marketed Products from Rubicon’s Ambernath Site

Click here to view therapeutic category